Etienne Lengliné
10PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 24, 2026
When evaluating targeted therapies in chronic lymphocytic leukemia, the absolute measure of treatment effect should be preferred.Vincent Lévy, Etienne Lengline, Sylvie Chevret
|Aug 26, 2025
LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL.Manon Delafoy, Mickaël F Bonnet, Etienne Lengliné
|Dec 09, 2024
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies.Rémy Dumont, Etienne Lengliné, Clara Delorme
|Jun 25, 2024
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia.Pierre Walczak, Sofiane Fodil, Nicolas Vignal
|Feb 11, 2023
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis.Marco Cerrano, Sylvie Chevret, Emmanuel Raffoux
|Dec 19, 2022
Enriching single-arm clinical trials with external controls: possibilities and pitfalls.Jérôme Lambert, Etienne Lengliné, Raphaël Porcher
Pageof 2
Frequent Collaborators
4 joint publications
Nicolas Boissel
3 joint publications
Sylvie Chevret
2 joint publications
Hervé Dombret
1 joint publications
Colombe Saillard
1 joint publications
Xavier Thomas
1 joint publications
Carlos Graux
1 joint publications
Yves Chalandon
1 joint publications
Thibaut Leguay
1 joint publications
Paul de Boissieu
1 joint publications
Eric Delabesse